GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Resources Double-Crane Pharmaceutical Co Ltd (SHSE:600062) » Definitions » 6-1 Month Momentum %

China Resources Double-Crane Pharmaceutical Co (SHSE:600062) 6-1 Month Momentum % : 31.54% (As of Apr. 29, 2024)


View and export this data going back to 1997. Start your Free Trial

What is China Resources Double-Crane Pharmaceutical Co 6-1 Month Momentum %?

6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2024-04-29), China Resources Double-Crane Pharmaceutical Co's 6-1 Month Momentum % is 31.54%.

The industry rank for China Resources Double-Crane Pharmaceutical Co's 6-1 Month Momentum % or its related term are showing as below:

SHSE:600062's 6-1 Month Momentum % is ranked better than
79.44% of 1114 companies
in the Drug Manufacturers industry
Industry Median: 3.47 vs SHSE:600062: 31.54

Competitive Comparison of China Resources Double-Crane Pharmaceutical Co's 6-1 Month Momentum %

For the Drug Manufacturers - Specialty & Generic subindustry, China Resources Double-Crane Pharmaceutical Co's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Resources Double-Crane Pharmaceutical Co's 6-1 Month Momentum % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, China Resources Double-Crane Pharmaceutical Co's 6-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where China Resources Double-Crane Pharmaceutical Co's 6-1 Month Momentum % falls into.



China Resources Double-Crane Pharmaceutical Co  (SHSE:600062) 6-1 Month Momentum % Calculation

6-1 Month Momentum % is calculated as following:

6-1 Month Momentum %=( Price 1-month ago / Price 6-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


China Resources Double-Crane Pharmaceutical Co  (SHSE:600062) 6-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


China Resources Double-Crane Pharmaceutical Co 6-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of China Resources Double-Crane Pharmaceutical Co's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


China Resources Double-Crane Pharmaceutical Co (SHSE:600062) Business Description

Traded in Other Exchanges
N/A
Address
No. 1, East Second Road, Lijing, Wangjing, Chaoyang District, Beijing, CHN, 100102
China Resources Double-Crane Pharmaceutical Co Ltd is a China-based pharmaceutical company. It is engaged in developing, manufacturing and marketing a variety of medical products. The company's products cover different fields such as infusion field, cardiovascular and cerebrovascular fields, pediatrics, endocrine field and other areas.

China Resources Double-Crane Pharmaceutical Co (SHSE:600062) Headlines

No Headlines